Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
NCT04357522Phase 3Not yet recruiting
- Sponsor
- Zhifei Green Bamboo
- Start
- Jul 2020
- Primary completion
- Mar 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of 15-valent pneumococcal conjugate vaccine in Pneumococcal pneumonia (PP), pneumococcal disease, sponsored by Zhifei Green Bamboo. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
15-valent pneumococcal conjugate vaccine
03
Conditions
Pneumococcal pneumonia (PP)pneumococcal disease
Beyond the preview
Go deeper on NCT04357522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357522.